Who we are

kalacura-AI™ is a molecular diagnostics company developing AI-enabled non-invasive technologies for precision monitoring in transplantation and oncology.

We are a multidisciplinary team of clinicians, scientists, and engineers working at the intersection of medicine, biology, and advanced data science to advance non-invasive disease monitoring.

The platform is supported by proprietary intellectual property and patent filings covering the underlying platform architecture and analytical framework.

Our current programmes include sponsor-funded research and feasibility studies in transplant medicine, with parallel oncology investigations underway.

The platform is currently undergoing validation for clinical translation, with initial deployment pathways being developed in parallel. At present, analyses are performed in research settings while regulatory pathways toward clinical use are pursued.